A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samples

Virginia Savova(Harvard University), Emanuele de Rinaldis(Target (United States)), Evis Havari(Sanofi (United States)), Frank O. Nestlé(Guy's and St Thomas' NHS Foundation Trust), Srinivas Shankara(Sanofi (United States)), Darren P. Baker(Biogen (United States)), Robert Marcus(King's College Hospital), Mathew Chamberlain(Sanofi (United States)), K. Klinger(Sanofi (France)), Richa Hanamsagar(Sanofi (United States))
Research Square
June 15, 2021
Cited by 0


Related Papers